Target intelligence / Profile preview

Animal venoms

Molecular classification
Other, Enzyme, Ion channel blocker, Receptor ligand, Antimicrobial peptide, G protein-coupled receptor ligand, Protease inhibitor
01

Overview

Animal venoms are complex, biologically active mixtures composed mainly of peptides and proteins, sometimes containing small molecules, produced by a broad range of animals including snakes, scorpions, spiders, bees, and marine organisms. Venoms function in predation, defense, and sometimes communication, exerting their effects by interacting with molecular targets such as ion channels, enzymes, and receptors. The components of venoms have high specificity for these targets, causing effects like paralysis, cell death, or disruption of physiological systems. These effects, while often harmful to humans, have inspired drug discovery for diverse diseases (hypertension, thrombosis, pain, neurodegenerative and cardiovascular diseases), with several venom-derived drugs approved or in development. Venom components are studied both as leads for therapeutics and for basic research, but the generic use of “animal venoms” is too broad for a precise molecular target entry and must be parsed into specific molecules for structured pharmacological databases. If structured information is required for a target, use the individual toxin or protein name (e.g., “Phospholipase A2”, “α-Bungarotoxin”, “Dendrotoxin”) rather than “animal venoms” as an entry.

Other names
VenomsAnimal toxinsAnimal-derived protein toxins
02

Mechanism of action

Variable; depends on the specific venom component: Enzyme inhibition, Ion channel blocking/modulation, Receptor antagonism/agonism, Protease activation/inhibition, Anticoagulation, Neurotoxicity.

03

Biological functions

Immobilization and predationDefenseSignal transductionImmune modulationCell deathDisruption of cardiovascular, nervous, and muscular systems
04

Disease associations

InfectionNeurodegenerative diseaseCancerCardiovascular diseasePainOther
05

Safety considerations

Systemic toxicityAnaphylaxisSevere neurotoxicityCardiovascular compromiseDifficulty in controlling selectivity and potency of crude mixturesImmune reactions against antivenom therapies
06

Interacting drugs

Captopril

5 more in the full profile.

Beyond the preview

Go deeper on Animal venoms.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Animal venoms.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call